Navigation Links
HistoSonics Expands Leadership Team As It Accelerates Growth
Date:9/19/2017

ANN ARBOR, Mich., Sept. 19, 2017 /PRNewswire/ -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy for the precise destruction of targeted tissues, announced three leadership team developments today:  

Josh Stopek, PhD
Josh Stopek, PhD
Jim Bertolina, PhD
Jim Bertolina, PhD
Tom Tefft
Tom Tefft

  • Veteran medical device executive Josh Stopek, PhD, who has led R&D and business development teams at Medtronic and Covidien, has joined HistoSonics as Vice President of Research & Development. Dr. Stopek is based in Minneapolis, where he will help HistoSonics build a presence in this rich medical device market.
                                
  • HistoSonics Co-founder and CTO Jim Bertolina, PhD, has been named to the newly created position of Chief Scientific Officer (CSO). As CSO, Dr. Bertolina will be responsible for leading the company's translational research efforts and further advancing the science of histotripsy, which serves as the basis for HistoSonics' innovative platform therapy.
                                      
  • Tom Tefft has been appointed to HistoSonics' Board of Directors. Mr. Tefft spent 24 years as an executive at Medtronic, most recently serving as President of Medtronic's neuromodulation business.

"I am extremely excited about the addition of Josh to our team, as I know him personally from our days together at superDimension/Covidien, and there is no one better to lead the development efforts of our new platform technology," said HistoSonics President and CEO Mike Blue. "As a company, we are in the process of accelerating our growth.  With Jim focused on translational research and future applications and Josh on getting this important technology to market, we are now well positioned to achieve significant development milestones for years to come." 

Jim Adox, Chairman of the HistoSonics Board of Directors, added, "We are very pleased to add Tom Tefft to the Board as we transition HistoSonics from a development company to a clinical-stage commercial company. Tom brings nearly 25 years of senior-level experience at Medtronic; his deep expertise will help guide the Company during this exciting growth stage."

About Josh Stopek, PhD

Dr. Stopek has more than 15 years of R&D leadership experience, including a strong background in developing image-guided technologies and bringing new platforms to market. He joins HistoSonics from Medtronic Lung Health, where he served as Senior Director of R&D and led a team of over 60 engineers. Previously, he spent eight years at Covidien, where he served in both R&D and Business Development leadership roles. Earlier in his career, Dr. Stopek was a Platform Leader in Advanced Technology R&D at US Surgical, and he was the co-founder and VP of a startup medical device company, VMSI. Dr. Stopek has significant experience in IP strategy, with over 100+ issued patents and another 200+ patents pending. Dr. Stopek received his BS, MS and PhD in Materials Science and Engineering from the University of Florida, where he also completed a fellowship in Neurosurgery and Neuroscience. 

About Jim Bertolina, PhD

Dr. Bertolina is a medical physics expert with more than 20 years of experience in medical device product innovation and research. After co-founding HistoSonics in 2009, he served as the company's Chief Technology Officer (CTO) for eight years, leading all of HistoSonics' product development and research efforts during that time.  Dr. Bertolina has overseen the development of HistoSonics' innovative therapeutic device used in a great number of preclinical applications, and has been responsible for growing HistoSonics' IP and trade secret portfolio.  Prior to HistoSonics, Dr. Bertolina served as Vice President, New Product Development at Xoran, Inc., Technical Director for the Stryker Navigation System at Stryker, Inc., and a Medical Physicist specializing in radiosurgery at Leibinger, Inc. Dr. Bertolina earned his BS and MS, both in Physics, from the University of Utah. He received his PhD and completed a postdoc in Medical Physics Research (Radiology and Radiotherapy) at the University of Virginia.

About Tom Tefft

Mr. Tefft was the Senior Vice President and President of Medtronic's $2B Neuromodulation business from 2009 to 2016, overseeing R&D, operations, and sales and marketing. Previously he held numerous finance leadership roles at Medtronic, including Corporate Controller, Vice President Finance for the Cardiac Rhythm Management business, and Vice President and Controller for Europe, Africa and Middle East. Earlier in his career, Mr. Tefft spent ten years at Price Waterhouse. In addition to serving on HistoSonics' board of directors, he serves on the board of directors of POPS! Diabetes Care, the American Nurses Foundation, and the Deans Advisory Board at the University of Wisconsin-Madison School of Business. Mr. Tefft received his BA in Accounting from the University of Wisconsin-Madison.

About HistoSonics

HistoSonics, Inc. was created to advance the development of histotripsy, a revolutionary science discovered and developed by leading scientists at the University of Michigan to provide improved therapies for patients. Our exclusive license to intellectual property, significant financial support and strategic partnerships have helped HistoSonics develop Robotically Assisted Sonic Therapy (RAST)™, a non-invasive, non-thermal approach to cancer care that is based on the science of histotripsy, using pulsed sound energy for the precise destruction of targeted tissues. HistoSonics' team of experienced specialists and industry leaders is based in Ann Arbor, Michigan.

For more information, please visit www.histosonics.com.

View original content with multimedia:http://www.prnewswire.com/news-releases/histosonics-expands-leadership-team-as-it-accelerates-growth-300522150.html


'/>"/>
SOURCE HistoSonics, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. SOM Biotech Licenses its First Product and Expands to the United States
2. ivWatch Launches OEM Solution, Expands Executive Team to Support Global Sales and Partnerships
3. Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
4. Twist Bioscience Expands Agreement to Pursue Higher Density Digital Data Storage on DNA with Microsoft and University of Washington
5. Leica Microsystems Expands EM Sample Prep Coverage through NCI Inc.
6. Hi-Tech Pharmaceuticals Expands With Opening of West Coast Distribution Center
7. Physician Partners of America Expands Again to Include Merritt Island
8. QIAGEN Expands Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer
9. Astute Medical Expands Relationship With bioMérieux, Inc. And Ortho Clinical Diagnostics To Enhance NephroCheck Test Market Access
10. CVS Health Expands Access to Opioid Overdose-Reversal Drug at CVS Pharmacy locations in Arizona, Georgia, Iowa and South Carolina
11. Kymanox Expands, Signs New Director of Manufacturing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance in ... medical-grade battery-powered display stand specifically designed for endoscopy environments. An innovative ... into a clinical solution to support the improvement of patient outcomes, ... Design ... Solution ...
(Date:10/5/2017)... Oct. 5, 2017  In response to the ... and Maxillofacial Surgeons (AAOMS) released prescribing recommendations that ... be used as a first-line therapy to manage ... Recognizing the value and ... Paper "Opioid Prescribing: Acute and Postoperative Pain Management" ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun ... NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is ... is geared towards children of all ages; it is a non-competitive, non-timed event, which ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the ... today its plans to open a flagship location in Covington, LA at 401 N. ... To Go store next to Office Depot in the Holiday Square shopping center. Its ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
Breaking Medicine News(10 mins):